vs
LOUISIANA-PACIFIC CORP（LPX）与Royalty Pharma plc（RPRX）财务数据对比。点击上方公司名可切换其他公司
Royalty Pharma plc的季度营收约是LOUISIANA-PACIFIC CORP的1.1倍（$622.0M vs $566.0M），Royalty Pharma plc净利率更高（34.4% vs -1.4%，领先35.9%），Royalty Pharma plc同比增速更快（4.8% vs -16.9%），过去两年Royalty Pharma plc的营收复合增速更高（4.6% vs -11.6%）
路易斯安那-太平洋公司（简称LP）是美国知名建材制造商，成立于1973年，是美国定向结构刨花板（OSB）生产的开创者，总部现位于田纳西州纳什维尔。作为全球最大的OSB生产商，公司还生产工程木建材产品，通过建材分销商、经销商及家居零售中心向建筑商和业主供货。
本公司是总部位于美国马萨诸塞州剑桥市的临床阶段生物制药企业，专注于研发可调节转化生长因子β（TGF-β）超家族蛋白的药物，该类蛋白在红细胞、肌肉、骨骼、血管等细胞与组织的生长修复过程中发挥核心作用。
LPX vs RPRX — 直观对比
营收规模更大
RPRX
是对方的1.1倍
$566.0M
营收增速更快
RPRX
高出21.7%
-16.9%
净利率更高
RPRX
高出35.9%
-1.4%
两年增速更快
RPRX
近两年复合增速
-11.6%
损益表 — Q4 FY2025 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $566.0M | $622.0M |
| 净利润 | $-8.0M | $214.2M |
| 毛利率 | 15.0% | — |
| 营业利润率 | -1.6% | 62.4% |
| 净利率 | -1.4% | 34.4% |
| 营收同比 | -16.9% | 4.8% |
| 净利润同比 | -112.9% | 2.9% |
| 每股收益（稀释后） | $-0.12 | $0.49 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收LPXRPRX
| Q4 25 | $566.0M | $622.0M | ||
| Q3 25 | $663.0M | $609.3M | ||
| Q2 25 | $755.0M | $578.7M | ||
| Q1 25 | $724.0M | $568.2M | ||
| Q4 24 | $681.0M | $593.6M | ||
| Q3 24 | $722.0M | $564.7M | ||
| Q2 24 | $814.0M | $537.3M | ||
| Q1 24 | $724.0M | $568.0M |
净利润LPXRPRX
| Q4 25 | $-8.0M | $214.2M | ||
| Q3 25 | $9.0M | $288.2M | ||
| Q2 25 | $54.0M | $30.2M | ||
| Q1 25 | $91.0M | $238.3M | ||
| Q4 24 | $62.0M | $208.2M | ||
| Q3 24 | $90.0M | $544.0M | ||
| Q2 24 | $160.0M | $102.0M | ||
| Q1 24 | $108.0M | $4.8M |
毛利率LPXRPRX
| Q4 25 | 15.0% | — | ||
| Q3 25 | 19.5% | — | ||
| Q2 25 | 23.6% | — | ||
| Q1 25 | 27.2% | — | ||
| Q4 24 | 23.8% | — | ||
| Q3 24 | 26.7% | — | ||
| Q2 24 | 32.3% | — | ||
| Q1 24 | 29.6% | — |
营业利润率LPXRPRX
| Q4 25 | -1.6% | 62.4% | ||
| Q3 25 | 2.7% | 70.1% | ||
| Q2 25 | 10.6% | 36.3% | ||
| Q1 25 | 16.6% | 94.0% | ||
| Q4 24 | 11.0% | 60.9% | ||
| Q3 24 | 16.1% | — | ||
| Q2 24 | 23.8% | 50.2% | ||
| Q1 24 | 20.0% | -13.0% |
净利率LPXRPRX
| Q4 25 | -1.4% | 34.4% | ||
| Q3 25 | 1.4% | 47.3% | ||
| Q2 25 | 7.2% | 5.2% | ||
| Q1 25 | 12.6% | 41.9% | ||
| Q4 24 | 9.1% | 35.1% | ||
| Q3 24 | 12.5% | 96.3% | ||
| Q2 24 | 19.7% | 19.0% | ||
| Q1 24 | 14.9% | 0.8% |
每股收益（稀释后）LPXRPRX
| Q4 25 | $-0.12 | $0.49 | ||
| Q3 25 | $0.13 | $0.67 | ||
| Q2 25 | $0.77 | $0.07 | ||
| Q1 25 | $1.30 | $0.55 | ||
| Q4 24 | $0.90 | $0.46 | ||
| Q3 24 | $1.28 | $1.21 | ||
| Q2 24 | $2.23 | $0.23 | ||
| Q1 24 | $1.48 | $0.01 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $292.0M | $618.7M |
| 总债务越低越好 | $348.0M | $9.0B |
| 股东权益账面价值 | $1.7B | $9.7B |
| 总资产 | $2.6B | $19.6B |
| 负债/权益比越低杠杆越低 | 0.20× | 0.92× |
8季度趋势，按日历期对齐
现金及短期投资LPXRPRX
| Q4 25 | $292.0M | $618.7M | ||
| Q3 25 | $316.0M | $938.9M | ||
| Q2 25 | $333.0M | $631.9M | ||
| Q1 25 | $256.0M | $1.1B | ||
| Q4 24 | $340.0M | $929.0M | ||
| Q3 24 | $346.0M | $950.1M | ||
| Q2 24 | $317.0M | $1.8B | ||
| Q1 24 | $244.0M | $843.0M |
总债务LPXRPRX
| Q4 25 | $348.0M | $9.0B | ||
| Q3 25 | $348.0M | $8.9B | ||
| Q2 25 | $348.0M | $8.0B | ||
| Q1 25 | $348.0M | $7.6B | ||
| Q4 24 | $348.0M | $7.6B | ||
| Q3 24 | $347.0M | $7.6B | ||
| Q2 24 | $347.0M | $7.6B | ||
| Q1 24 | $347.0M | $6.1B |
股东权益LPXRPRX
| Q4 25 | $1.7B | $9.7B | ||
| Q3 25 | $1.7B | $9.6B | ||
| Q2 25 | $1.7B | $9.5B | ||
| Q1 25 | $1.7B | $9.8B | ||
| Q4 24 | $1.7B | $10.3B | ||
| Q3 24 | $1.7B | $10.3B | ||
| Q2 24 | $1.7B | $9.8B | ||
| Q1 24 | $1.6B | $9.9B |
总资产LPXRPRX
| Q4 25 | $2.6B | $19.6B | ||
| Q3 25 | $2.6B | $19.3B | ||
| Q2 25 | $2.7B | $18.3B | ||
| Q1 25 | $2.6B | $17.6B | ||
| Q4 24 | $2.6B | $18.2B | ||
| Q3 24 | $2.6B | $18.0B | ||
| Q2 24 | $2.5B | $17.7B | ||
| Q1 24 | $2.5B | $16.1B |
负债/权益比LPXRPRX
| Q4 25 | 0.20× | 0.92× | ||
| Q3 25 | 0.20× | 0.93× | ||
| Q2 25 | 0.20× | 0.84× | ||
| Q1 25 | 0.21× | 0.78× | ||
| Q4 24 | 0.21× | 0.74× | ||
| Q3 24 | 0.21× | 0.74× | ||
| Q2 24 | 0.21× | 0.78× | ||
| Q1 24 | 0.21× | 0.62× |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $67.0M | $827.1M |
| 自由现金流经营现金流 - 资本支出 | $-8.0M | — |
| 自由现金流率自由现金流/营收 | -1.4% | — |
| 资本支出强度资本支出/营收 | 13.3% | — |
| 现金转化率经营现金流/净利润 | — | 3.86× |
| 过去12个月自由现金流最近4个季度 | $91.0M | — |
8季度趋势，按日历期对齐
经营现金流LPXRPRX
| Q4 25 | $67.0M | $827.1M | ||
| Q3 25 | $89.0M | $702.6M | ||
| Q2 25 | $162.0M | $364.0M | ||
| Q1 25 | $64.0M | $596.1M | ||
| Q4 24 | $105.0M | $742.5M | ||
| Q3 24 | $183.0M | $703.6M | ||
| Q2 24 | $212.0M | $658.2M | ||
| Q1 24 | $105.0M | $664.6M |
自由现金流LPXRPRX
| Q4 25 | $-8.0M | — | ||
| Q3 25 | $5.0M | — | ||
| Q2 25 | $94.0M | — | ||
| Q1 25 | $0 | — | ||
| Q4 24 | $43.0M | — | ||
| Q3 24 | $139.0M | — | ||
| Q2 24 | $176.0M | — | ||
| Q1 24 | $64.0M | — |
自由现金流率LPXRPRX
| Q4 25 | -1.4% | — | ||
| Q3 25 | 0.8% | — | ||
| Q2 25 | 12.5% | — | ||
| Q1 25 | 0.0% | — | ||
| Q4 24 | 6.3% | — | ||
| Q3 24 | 19.3% | — | ||
| Q2 24 | 21.6% | — | ||
| Q1 24 | 8.8% | — |
资本支出强度LPXRPRX
| Q4 25 | 13.3% | — | ||
| Q3 25 | 12.7% | — | ||
| Q2 25 | 9.0% | — | ||
| Q1 25 | 8.8% | — | ||
| Q4 24 | 9.1% | — | ||
| Q3 24 | 6.1% | — | ||
| Q2 24 | 4.4% | — | ||
| Q1 24 | 5.7% | — |
现金转化率LPXRPRX
| Q4 25 | — | 3.86× | ||
| Q3 25 | 9.89× | 2.44× | ||
| Q2 25 | 3.00× | 12.06× | ||
| Q1 25 | 0.70× | 2.50× | ||
| Q4 24 | 1.69× | 3.57× | ||
| Q3 24 | 2.03× | 1.29× | ||
| Q2 24 | 1.32× | 6.45× | ||
| Q1 24 | 0.97× | 139.10× |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
LPX
| OS Bvalueadd | $472.0M | 83% |
| Other | $84.0M | 15% |
| Otherproducts | $10.0M | 2% |
RPRX
| Financial Royalty Assets | $592.4M | 95% |
| Royalty Income Other | $29.6M | 5% |
